A Phase I Safety, Efficacy, and Pharmacokinetic Study of 2',3'-Dideoxyinosine (ddI) Administered Twice Daily to Patients With AIDS or AIDS Related Complex
Clinical trial NCT00000710 · COMPLETED
Trial details
- NCT number
- NCT00000710
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.